Cargando…
Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines
The purpose of this study was to compare the growth-inhibitory effect of cisplatin–paclitaxel with that obtained with a cisplatin–docetaxel combination and to assess the type of interaction. Concomitant use of taxanes and cisplatin was studied in seven human ovarian carcinoma cell lines, using the 9...
Autores principales: | Engblom, P, Rantanen, V, Kulmala, J, Helenius, H, Grènman, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362186/ https://www.ncbi.nlm.nih.gov/pubmed/9888470 http://dx.doi.org/10.1038/sj.bjc.6690046 |
Ejemplares similares
-
Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
por: Rantanen, V., et al.
Publicado: (1994) -
Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines
por: Al Balushi, Najwa, et al.
Publicado: (2022) -
No supra-additive effects of goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro
por: Hermann, Robert M, et al.
Publicado: (2007) -
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors
por: Ferlini, C, et al.
Publicado: (2000) -
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)